Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)
China
· Delayed Price · Currency is CNY 8.45
-0.26 (-2.99%)
May 30, 2025, 3:04 PM CST
SHE:002693 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | 175.77 | 231.06 | 250.33 | 303.56 | 251.48 | 327.83 | Upgrade
|
| Other Revenue | 4.87 | 4.87 | 24.42 | 16.74 | 17.96 | 18.82 | Upgrade
|
| Revenue | 180.64 | 235.93 | 274.75 | 320.29 | 269.44 | 346.65 | Upgrade
|
| Revenue Growth (YoY) | -30.29% | -14.13% | -14.22% | 18.87% | -22.27% | 2.79% | Upgrade
|
| Cost of Revenue | 79.39 | 82.41 | 94.65 | 87.68 | 65.74 | 99.1 | Upgrade
|
| Gross Profit | 101.25 | 153.52 | 180.1 | 232.61 | 203.7 | 247.55 | Upgrade
|
| Selling, General & Admin | 143.03 | 175.23 | 202.13 | 264.62 | 244.34 | 273.04 | Upgrade
|
| Research & Development | 12.02 | 7.96 | 14.59 | 10.62 | 12.18 | 13.14 | Upgrade
|
| Other Operating Expenses | 12.79 | 6.02 | 7.71 | 7.03 | 7.18 | 7.83 | Upgrade
|
| Operating Expenses | 169.06 | 190.35 | 224.34 | 282.23 | 264.06 | 294.58 | Upgrade
|
| Operating Income | -67.82 | -36.83 | -44.24 | -49.62 | -60.35 | -47.03 | Upgrade
|
| Interest Expense | -8.89 | -9.58 | -11.19 | -9.03 | -10.01 | -9.83 | Upgrade
|
| Interest & Investment Income | 0.57 | 2.79 | 4.75 | 4.17 | 2.94 | 5.22 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.12 | 0.12 | 0.01 | -0.1 | -0.29 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.48 | -0.04 | -0.05 | -0.81 | -4.63 | -1.66 | Upgrade
|
| EBT Excluding Unusual Items | -76.49 | -43.55 | -50.71 | -55.39 | -72.34 | -53.29 | Upgrade
|
| Gain (Loss) on Sale of Investments | -39.97 | -39.85 | -0.06 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.17 | 0.35 | 29.9 | 13.74 | -1.21 | 37.16 | Upgrade
|
| Asset Writedown | -0.37 | - | -2.1 | - | -9.95 | -0.06 | Upgrade
|
| Other Unusual Items | 10.08 | 10.08 | 14.09 | 1.29 | 4.72 | 26.72 | Upgrade
|
| Pretax Income | -106.92 | -72.97 | -8.88 | -40.36 | -78.78 | 10.52 | Upgrade
|
| Income Tax Expense | -0.78 | -0.99 | -0.38 | 0.45 | 1.17 | 1.49 | Upgrade
|
| Earnings From Continuing Operations | -106.14 | -71.98 | -8.5 | -40.81 | -79.95 | 9.03 | Upgrade
|
| Minority Interest in Earnings | 19.18 | 21.23 | 17.51 | 20.48 | 26.62 | 15.63 | Upgrade
|
| Net Income | -86.96 | -50.74 | 9.01 | -20.33 | -53.33 | 24.66 | Upgrade
|
| Net Income to Common | -86.96 | -50.74 | 9.01 | -20.33 | -53.33 | 24.66 | Upgrade
|
| Shares Outstanding (Basic) | 422 | 423 | 451 | 407 | 410 | 411 | Upgrade
|
| Shares Outstanding (Diluted) | 422 | 423 | 451 | 407 | 410 | 411 | Upgrade
|
| Shares Change (YoY) | -14.00% | -6.16% | 10.85% | -0.91% | -0.17% | 0.58% | Upgrade
|
| EPS (Basic) | -0.21 | -0.12 | 0.02 | -0.05 | -0.13 | 0.06 | Upgrade
|
| EPS (Diluted) | -0.21 | -0.12 | 0.02 | -0.05 | -0.13 | 0.06 | Upgrade
|
| Free Cash Flow | -36.18 | -37.56 | -7.77 | -8.09 | -62.07 | 15.08 | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.09 | -0.02 | -0.02 | -0.15 | 0.04 | Upgrade
|
| Gross Margin | 56.05% | 65.07% | 65.55% | 72.62% | 75.60% | 71.41% | Upgrade
|
| Operating Margin | -37.54% | -15.61% | -16.10% | -15.49% | -22.40% | -13.57% | Upgrade
|
| Profit Margin | -48.14% | -21.51% | 3.28% | -6.35% | -19.79% | 7.11% | Upgrade
|
| Free Cash Flow Margin | -20.03% | -15.92% | -2.83% | -2.52% | -23.04% | 4.35% | Upgrade
|
| EBITDA | -21.4 | 14.35 | 13.3 | 4.71 | -3.26 | 11.98 | Upgrade
|
| EBITDA Margin | -11.85% | 6.08% | 4.84% | 1.47% | -1.21% | 3.46% | Upgrade
|
| D&A For EBITDA | 46.41 | 51.18 | 57.54 | 54.33 | 57.09 | 59.01 | Upgrade
|
| EBIT | -67.82 | -36.83 | -44.24 | -49.62 | -60.35 | -47.03 | Upgrade
|
| EBIT Margin | -37.54% | -15.61% | -16.10% | -15.49% | -22.40% | -13.57% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 14.15% | Upgrade
|
| Revenue as Reported | 180.64 | 235.93 | 274.75 | 320.29 | 269.44 | 346.65 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.